Lectures

Respiratory Question Set 2

by Lecturio USMLE
(1)

Questions about the lecture
My Notes
  • Required.
Save Cancel
    Report mistake

    About the Lecture

    The lecture Respiratory Question Set 2 by Lecturio USMLE is from the course Respiratory Pathology – Board-Style Questions.


    Included Quiz Questions

    1. Isolate the child immediately until treatment is established
    2. Administer BCG to the all the family members
    3. Provide INH prophylaxis to the rest of the family
    4. Provide INH prophylaxis to all contacts
    1. Bronchiolitis
    2. Bronchial asthma
    3. Bacterial pneumonia
    4. Bronchial foreign body
    5. Croup
    1. Gene for mitogen-activated protein (MAP) kinase phosphatase-1 is activated by inhaled corticosteroids, which produces anti-inflammatory effects.
    2. β2-agonists reverse bronchoconstriction but do not control underlying inflammation because inflammatory cells do not express β2 adrenergic receptors.
    3. Theophylline activates histone acetyltransferase and therefore exerts anti-inflammatory activity in bronchial asthma.
    4. Antileukotrienes exert their beneficial effects in bronchial asthma by blocking cys-LT2-receptors.
    5. Omalizumab acts by blocking both circulating IgE and cell-bound IgE to produce therapeutic effects in bronchial asthma.
    1. In patients with high-level nasal resistance, the opening of mouth during sleep prevents apnea/hypopnea episodes.
    2. Most common site of collapse of pharyngeal airway during sleep apnea is at level of base of tongue.
    3. Overnight blood pressure monitoring in the patient may not show a fall during sleep from blood pressure while awake.
    4. Episodes of apnea and hypopnea are more likely to occur during deeper stages of non-rapid eye movement (NREM) sleep.
    5. Gynoid obesity is associated with apnea and hypopnea more frequently as compared to android obesity.
    1. Anti-CRMP5
    2. Anti-Hu
    3. Anti-Ri
    4. Anti-amphiphysin
    5. Anti-Yo
    1. Inflamed bronchus with hypertrophy and hyperplasia of mucous glands
    2. Airway hypersensitivity
    3. Abnormal permanent bronchial dilation
    4. Destruction of alveolar septa and enlarged air spaces
    5. Chronic granulomatous inflammation with bilateral hilar lymphadenopathy
    1. Asbestosis
    2. Drug induced interstitial lung disease
    3. Tuberculosis
    4. Allergic bronchopulmonary aspergillosis
    5. Sarcoidosis
    1. Congestive heart failure
    2. Uremia
    3. Hypothyroidism
    4. Chylothorax
    5. Sarcoidosis
    1. Defective chloride transport
    2. Abnormal ciliary motion
    3. Gluten hypersensitivity
    4. Bronchial hypersensitivity
    5. Fibrosis of lung parenchyma
    1. Decrease in FEV1 after methacholine
    2. Decreased FVC on pulmonary tests
    3. Decreased oxygen saturation
    4. Paroxysmal nocturnal dyspnea
    5. Chest X-ray showing hyperinflation
    1. Small cell carcinoma of the lung
    2. Tuberculoma
    3. Squamous cell carcinoma of the lung
    4. Adenocarcinoma of the lung
    5. Lung abscess
    1. Neonatal respiratory distress syndrome (NRDS)
    2. Congenital heart anomaly with right-to-left shunt
    3. Pneumonia
    4. Sepsis
    5. Tracheoesophageal fistula
    1. Exercise induced bronchospasm
    2. Pneumonia
    3. Chronic obstructive pulmonary disease
    4. Bronchopulmonary dysplasia
    5. Tracheoesophageal fistula
    1. Type I hypersensitivity
    2. Exercise
    3. Type IV hypersensitivity
    4. Smoking
    5. Chronic obstructive pulmonary disease
    1. Spontaneous pneumothorax
    2. Pneumonia
    3. Asthma
    4. Chronic obstructive pulmonary disease
    5. Tension pneumothorax
    1. Hemosiderin-laden macrophages
    2. Amyloid deposits
    3. Neutrophils and macrophages in alveolar lumens
    4. Large air spaces
    5. Primitive-appearing, small cells
    1. α1 antitrypsin deficiency
    2. Pneumonia
    3. Asthma
    4. Pulmonary edema
    5. Lung cancer
    1. Surfactant administration and oxygen therapy
    2. Oxygen therapy
    3. Antibiotics
    4. No therapy right away, only observation
    5. Emergency surgical repair of tracheoesophageal fistula
    1. Short acting β2 agonists
    2. Systemic corticosteroids
    3. Long acting β2 agonists
    4. No therapy, only avoidance of exercise
    5. Aminophylline
    1. Right-heart catheterization
    2. Holter monitoring
    3. Lung biopsy
    4. Trans-bronchial biopsy
    5. PET scan of the heart.
    1. Asthma attack
    2. Atelectasis
    3. Neuromuscular disease
    4. Carbon monoxide poisoning
    5. Acute respiratory distress syndrome
    1. Granulomatosis with polyangiitis
    2. Systemic lupus erythematosus
    3. Pulmonary and renal tuberculosis
    4. Goodpasture’s disease
    5. Pulmonary aspergillosis
    1. Pleural effusion
    2. Atelectasis
    3. Pneumothorax
    4. Pulmonary embolism
    5. Pneumonia
    1. Pleural effusion
    2. Pneumonia
    3. Acute bronchitis
    4. Pulmonary tuberculosis
    5. Primary Spontaneous Pneumothorax (PSP)
    1. Bronchiolitis
    2. Laryngotracheitis
    3. Asthma
    4. Rhinopharyngitis
    5. Sinusitis
    1. Nasal polyposis
    2. Septal deviation
    3. Nonallergic rhinopathy
    4. Juvenile nasopharyngeal angiofibroma
    5. Foreign body
    1. Acute sinusitis
    2. Streptococcal pharyngitis
    3. Diphteria
    4. Common cold
    5. Nonallergic vasomotor rhinitis
    1. Epstein-Barr virus
    2. HIV
    3. Hepatitis B virus
    4. Human T-lymphotropic virus type I
    5. Human papillomavirus
    1. Laryngeal carcinoma
    2. Polypoid corditis
    3. Vocal cord nodule
    4. Leukoplakia
    5. Acute laryngitis
    1. Respiratory distress syndrome
    2. Bacterial pneumonia
    3. Transient tachypnea of the newborn
    4. Cyanotic congenital heart disease
    5. Pneumothorax
    1. Pneumonia
    2. Sarcoidosis
    3. Histoplasmosis
    4. Tuberculosis
    5. Lung cancer
    1. Streptococcus pneumoniae
    2. Mycoplasma pneumoniae
    3. Chlamydia pneumoniae
    4. Legionella pneumophila
    5. Haemophilus influenzae
    1. Mycoplasma pneumonia
    2. Chlamydia psittaci
    3. Haemophilus influenza
    4. Staphylococcus aureus
    5. Streptococcus pneumoniae
    1. FEV1/FVC of 65 %
    2. FEV1 of 82 %
    3. Decreased total lung capacity
    4. Increased DLCO
    5. Metabolic acidosis
    1. Activation of T lymphocytes
    2. Formation of caseating granulomas
    3. Release of toxins by spirochete
    4. Activation of Langerhans cells
    5. Loss of protection against proteases
    1. Increased pulmonary arterial resistance
    2. Decreased carbon dioxide content of the arterial blood
    3. Increased pH of the arterial blood
    4. Increased cerebral vascular resistance
    5. Increased right ventricle compliance
    1. Small cell lung cancer
    2. Mesothelioma
    3. Metastatic lung disease
    4. Non-small cell lung cancer
    5. Pulmonary hamartoma
    1. Tumors seeded via the pulmonary veins
    2. Infection of the lung parenchyma with a gram negative bacteria grown on charcoal yeast agar
    3. Proliferation of cells that contain glands which produce mucin
    4. Malignant transformation of neuroendocrine cells
    5. Aspergillus infection leading to a formation of a “fungus ball”
    1. Benign tumor of the thymus
    2. Superior vena cava syndrome
    3. Anaplastic thyroid cancer
    4. Mediastinitis
    5. Thyroglossal duct cyst
    1. Drug-induced pulmonary disease
    2. Radiation-induced pulmonary disease
    3. Granulomatous lung disease
    4. Cardiogenic pulmonary edema
    5. Idiopathic pulmonary fibrosis
    1. Spirometry
    2. Chest CT Scan
    3. Cardiac Catheterization
    4. Measurement of protease inhibitor
    5. Arterial Blood Gases (ABG)
    1. Primary respiratory acidosis
    2. Non-anion gap metabolic acidosis
    3. Compensatory respiratory acidosis
    4. Anion gap metabolic acidosis with respiratory alkalosis
    5. Primary respiratory alkalosis
    1. Chronic obstructive pulmonary disease
    2. Bronchiectasis
    3. Idiopathic pulmonary fibrosis
    4. Asbestosis
    5. Obesity hypoventilation syndrome
    1. Bronchiectasis
    2. Chronic obstructive pulmonary disease
    3. Alpha 1 antitrypsin deficiency
    4. Chronic bronchitis
    5. Tuberculosis
    1. Gender
    2. Race
    3. Occupational history
    4. Drugs
    5. Past medical history
    1. Small cell lung cancer
    2. Adenocarcinoma of the lung
    3. Squamous cell carcinoma of the lung
    4. Large cell carcinoma
    5. Bronchial carcinoid tumor
    1. Granulomatosis with polyangiitis
    2. Systemic lupus erythematosus
    3. Pulmonary and renal tuberculosis
    4. Goodpasture’s disease
    5. Pulmonary aspergillosis

    Author of lecture Respiratory Question Set 2

     Lecturio USMLE

    Lecturio USMLE


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0